LUNDBECKFONDEN EMERGE
Lundbeckfonden Emerge seeks to identify and initiate commercial development of scientific opportunities which it considers from its analysis have high commercial potential. The main objective is to turn scientific discoveries and early stage opportunities into commercial ventures with a maturity that allows for full venture financing. Lundbeckfonden Emerge not only offers limited financing for selected cases but also offers seasoned advice or direct participation in new ventures, as part of i... ts unique model to optimize the outcome of the venture to the benefit of all stakeholders. Lundbeckfonden Emerge will seek to develop select projects together with founders and will take on an active role from mentoring to active project management, as is considered optimal for the outcome of the specific project. In this way, Lundbeckfonden Emerge is not a replication of traditional seed funds, but rather a unique way of using research funds to get to commercially viable projects.
LUNDBECKFONDEN EMERGE
Industry:
Finance
Founded:
2012-01-01
Status:
Active
Contact:
+45 39 12 80 00
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Apple Mobile Web Clips Icon Google Tag Manager Nginx Organization Schema PHP Mobile Optimized FLoC Opt-Out Drupal
Similar Organizations
Comeback Capital
Comeback Capital is a pre-seed stage venture fund, that looks fund the buzzing startup ecosystem in the Midwest.
EuropeFX
EuropeFX offers a web-based trading platform for trading Forex, indices, CFDs, shares, and cryptocurrencies.
Current Employees Featured
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-02-15 | NMD Pharma | Lundbeckfonden Emerge investment in Venture Round - NMD Pharma | 35 M EUR |
| 2021-05-04 | Cytoki Pharma | Lundbeckfonden Emerge investment in Series A - Cytoki Pharma | 45 M USD |
| 2021-01-13 | IO Biotech | Lundbeckfonden Emerge investment in Series B - IO Biotech | 127 M EUR |
| 2019-06-24 | AFYX Therapeutics | Lundbeckfonden Emerge investment in Debt Financing - AFYX Therapeutics | 13 M USD |
| 2018-03-23 | NMD Pharma | Lundbeckfonden Emerge investment in Series A - NMD Pharma | 38 M EUR |
| 2017-05-09 | AFYX Therapeutics | Lundbeckfonden Emerge investment in Series A - AFYX Therapeutics | 16.2 M EUR |
| 2016-07-01 | NMD Pharma | Lundbeckfonden Emerge investment in Venture Round - NMD Pharma | 2.7 M EUR |